Janus Kinase Inhibitor
10 drugs across 4 manufacturers|0 Generic,10 Brand
The Janus Kinase Inhibitor class contains 10 NDCs from 4 manufacturers (0 generic, 10 brand), at an average NADAC of $180.87 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
10
0G / 10B
Manufacturers
4
Avg $180.8705/unit
Avg 7d Change
+0.04%
Across 5 drugs with changes
7d Activity
of 10 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Frequently Asked Questions
How many drugs are in the Janus Kinase Inhibitor class?
The Janus Kinase Inhibitor class contains 10 NDCs from 4 manufacturers — 0 generic and 10 brand products.
What is the average price of Janus Kinase Inhibitor drugs?
The average NADAC for the Janus Kinase Inhibitor class is $180.8705 per unit across 10 NDCs.
Which manufacturers make Janus Kinase Inhibitor drugs?
4 manufacturers make drugs in the Janus Kinase Inhibitor class. Ranked by number of NDCs, the largest are Pfizer Inc. (4), AbbVie Inc. (3), Eli Lilly and Company (2), Incyte Corporation (1).
How has Janus Kinase Inhibitor pricing changed recently?
Over the past 7 days, 3 NDCs in this class rose and 2 fell, with a class-wide average change of +0.0%.
Manufacturer Breakdown
4 manufacturers producing drugs in this therapeutic class
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
RINVOQ ER 45 MG TABLET Upadacitinib | $458.5378 per EA | -0.09% |
RINVOQ ER 15 MG TABLET Upadacitinib | $228.9190 per EA | +0.06% |
RINVOQ ER 30 MG TABLET Upadacitinib | $228.7721 per EA | +0.29% |
XELJANZ XR 11 MG TABLET tofacitinib | $207.8483 per EA | +0.05% |
CIBINQO 100 MG TABLET abrocitinib | $196.5694 per EA | — |
OLUMIANT 4 MG TABLET baricitinib | $184.6623 per EA | — |
XELJANZ 10 MG TABLET tofacitinib | $103.5456 per EA | — |
OLUMIANT 2 MG TABLET baricitinib | $92.2583 per EA | — |
XELJANZ 5 MG TABLET tofacitinib | $73.5726 per EA | -0.13% |
OPZELURA 1.5% CREAM ruxolitinib | $34.0201 per GM | 0.00% |